76Bio
New York, US · Founded 2020 · Delaware corporation
Founders & leadership
DT
David TanenNamed on SEC filing
CM
Christopher M. WilfongNamed on SEC filing
AK
Angela KoehlerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$22.2M disclosed across 2 rounds · 2021–2023
▶$12.2MraisedFeb 2023 · 32 investors · BiotechnologyRule 506(b)
▶$12.2MraisedFeb 2023 · 32 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher M. WilfongExecutive Officer, Director, Promoter
- David TanenDirector, Promoter
- Angela KoehlerDirector
- Offering amount
- $12.2M
- Amount sold
- $12.2M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$10MraisedJan 2022 · 44 investors · BiotechnologyRule 506(b)
▶$10MraisedJan 2022 · 44 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David TanenExecutive Officer, Director, Promoter
- Christopher M. WilfongExecutive Officer, Director, Promoter
- Angela KoehlerDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has 76Bio raised?
- 76Bio has disclosed $22.2M raised across 2 rounds.
- Where is 76Bio headquartered?
- 76Bio is headquartered in New York, US.